Iridex (IRIX) Return on Capital Employed Growth (1y) (2012 - 2026)
Iridex (IRIX) Return on Capital Employed Growth (1y) (2012 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.07 Bn | 193.46 Bn | 7.27 Bn | -286.00 |
| 2 | Stryker | 127.90 Bn | 124.43 Bn | 4.50 Bn | 6,388.00 |
| 3 | Medtronic | 118.84 Bn | 109.62 Bn | 6.41 Bn | 39.00 |
| 4 | Boston Scientific | 73.33 Bn | 72.79 Bn | 3.85 Bn | 200.00 |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | -41.00 |
| 6 | Dexcom | 34.46 Bn | 32.51 Bn | 830.00 Mn | 879.00 |
| 7 | GE HealthCare Technologies | 33.91 Bn | 31.81 Bn | 2.18 Bn | -2,494.00 |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 632.00 |
| 9 | Steris | 23.12 Bn | 22.64 Bn | 684.20 Mn | 216.00 |
| 10 | Iridex | 13.32 Mn | 8.64 Mn | 4.30 Mn | -73.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | 1,422.00 |
| Jan 3, 2026 | 4,691.00 |
| Sep 27, 2025 | 5,588.00 |
| Jun 28, 2025 | 4,643.00 |
| Mar 29, 2025 | 2,905.00 |
| Dec 28, 2024 | -1,738.00 |
| Sep 28, 2024 | -4,071.00 |
| Jun 29, 2024 | -3,353.00 |
| Mar 30, 2024 | -3,348.00 |
| Dec 30, 2023 | -2,188.00 |
| Sep 30, 2023 | -926.00 |
| Jul 1, 2023 | -847.00 |
| Apr 1, 2023 | -765.00 |
| Dec 31, 2022 | -692.00 |
| Oct 1, 2022 | -472.00 |
| Jul 2, 2022 | -330.00 |
| Apr 2, 2022 | 1,215.00 |
| Apr 3, 2021 | -89.00 |
| Mar 28, 2020 | 864.00 |
| Dec 28, 2019 | 504.00 |